Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis

NCT00889694 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Early Ankylosing Spondylitis

Interventions

DRUG: Tripterygium
DRUG: Sulfasalazine
DRUG: placebo

Sponsor

Sun Yat-sen University